chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have been sick; running nose; Coughing; very tired/Fatigue; Dizzy; Fever; have a reaction in my arm; I still have a small lumps in my arms; This is a spontaneous report from a contactable consumer (patient, self-reported). A 29-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, lot number and expiry date were not reported) via an unspecified route of administration, on 30July2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 30July2021, Patient experienced have a reaction in my arm and I still have a small lump in my arms. It was reported that Consumer stated, I was having a hard time finding out information on the side effects other than those main side effects which I know you guys are happy to record what people experiencing so I am happy to share that with you, but I wanted to know. I know it can cause tiredness, start nausea, throwing up, fever(Not clarified hence not captured in tab) things like that but what about running nose and coughing was that common as well because I did receive my first dose and I did have a reaction in my arm which I was told was common and I have been sick all week but days later and there was a concern may be I have Covid (Not clear hence not captured in tab) but maybe it was just from the vaccine and no one seems to know if the running nose or coughing was also a side effects in vaccine and I can't find it listed anywhere. Consumer stated, the reaction in my arm was immediate that was the 30Jul2021 and then next day I still have a small lump in my arms but that happened immediately after and on a following day I did fall under the weather but nothing horrible just a very tired, fatigue, I felt dizzy and on Sunday two days later I started feeling better and then last night I started getting sick again and I woke up very and I have been sick since. Consumer stated, No, I have talked with my doctor let know her and I was taking Tylenol to trying to get my fever down. Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
pt recv vax 6FEB96;pre-vaccination IgG titer on 9NOV94 was 0;post vax IgG titer on 10APR96 was 0.12 (positive seroconversion @ 0.15 for the test performed);no further details were provided;
fever: 102.8, chills, muscles aches, "fuzzy" head, took 2 advil, fever broke after few hours, aches remained for 42 hours,  repeated advil twice during that time.   much better now  (vaccination was working)
Refrigerator went in and out of range while there was flu vaccine in it. Doses were administered - no adverse event This spontaneous case initially received on 02-Nov-2016, was reported by a health professional and concerns an 81 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 08-Sep-2016, the patient received AFLURIA for indication not reported. Dose regimen: Not reported. Route of administration: Not reported. Batch number: WT53706. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 08-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. The patients will be contacted for revaccination.
Pt felt scratchy throat, said it felt like a lump was forming in throat. Benadryl 50mg PO x1 given as precaution, Pt kept for 15 extra Min for observation
Rash started developing all over my body, on both of my forearms and all over my neck, started moving up to my face; Rash started developing all over my body, on both of my forearms and all over my neck, started moving up to my face; Rash started developing all over my body, on both of my forearms and all over my neck, started moving up to my face; Rash started developing all over my body, on both of my forearms and all over my neck, started moving up to my face; Have rash on my chest, it look like hives; Migraine; This is a spontaneous report from a contactable consumer (Patient).   A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 28Jul2021 as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 02Aug2021, the patient experienced Migraine. On 03Aug2021, the patient experienced Rash started developing all over my body, on both of my forearms and all over my neck, started moving up to my face and Have rash on my chest, it look like hives. It was reported that Consumer stated, I got my Pfizer Vaccine last week on Wednesday and on Monday I had a migraine and on Tuesday a rash all started developing all over my body now it's Thursday I have a rash on both of my forearms and rash all over my neck, started moving up to my face and I have rash on my chest, it look like hives my little Pink sheet from the(Clarification unknown) says to call this number to report any side effects but I am hoping if you could tell me what to take to counteract, so it can go away and how long the rash was normally being reported or how long it stays. Outcome of all the events was unknown.  Information about the Lot/batch number has been requested.
Information has been received from a physician concerning a 22 year old female with no pertinent medical history who in June 2008, was vaccinated intramuscularly with a first 0.5 ml dose of GARDASIL. Concomitant therapy included oral contraceptive. "One week after administration of her first dose of GARDASIL", the patient developed generalized pruritic rash on her body. The patient took BENADRYL and then symptoms resolved when the patient woke up "the next morning". "One week later", the rash reappeared for the second time and resolved the next day after taking BENADRYL. The rash reappeared for the third time "one week later" and again symptoms resolved after taking BENADRYL. The patient was seen in office. These events were also reported as a "head to toe rash" that developed one week post vaccination which resolved the next morning after OTC BENADRYL use. The rash returned a second time about one week after the first rash appeared which again resolved after using OTC BENADRYL.  Follow-up information was received from the physician via phone call on 08-SEP-2008 indicating that the patient received the first dose of GARDASIL on 27-JUN-2008. The patient went to bed one night and woke up the next day with a total body rash one week after the injection. The patient took BENADRYL and the rash resolved. "One week later", the same total body rash reappeared. After taking hydrochloride BENADRYL, the rash resolved. "One week later", the same total  body rash reappeared for the third time. After taking BENADRYL, the rash resolved. So the patient had 3 episodes of total body rash that resolved with BENADRYL. On 27-AUG-2008 the patient returned for her second dose of GARDASIL and reported her experiences to the physician. As far as the physician knows, no further episodes had occurred. Additional information has been requested.
Initial information received on 16-Oct-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 17 years old patient who experienced painful linear "rash" all the way across and under both breast, while he/she received vaccine FLUZONE QUADRIVALENT. The patient's past vaccination(s) included Flu vaccine. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medication was none reported as No other vaccine was given. On 15-Oct-2018, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT6301LA via unknown route in the right deltoid. On an unknown date, the patient developed a non-serious painful linear "rash" all the way across and under both breast (rash) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. (Other relevant tests included No lab data.) Final diagnosis was painful linear "rash" all the way across and under both breast. It was not reported if the patient received a corrective treatment. It was also reported that Pharm D recommended Hydrocortisone cream and Benadryl. The patient outcome is reported as Unknown for painful linear "rash" all the way across and under both breast. List of documents held by sender: none.
On 12/05/2021, I had a heart attack. I called an ambulance and was taken to the hospital. On I had a stent on 12/07/202. I stayed 4 days in the hospital. I was told it was a widow maker heart attack. My heart tissues were damaged. I am now taking several medications due to the heart attack. I am a vegetarian and no one in my family has heart issues. This is very unusual. Three weeks before the vaccine, I had blood work and it indicated that my blood work was good. I now go to rehab three days a week. This has affected my life and can not do the things I use to.
Patient received PNEUMOVAX 23 and FLUZONE HD in her left arm on 11-4-14. Patient came to pharmacy on 11-14-14 (Yes, 10 days later) and stated the night of the shots she was red x 7 days, vomiting x 4 days, and now itching. Told patient to take BENADRYL for itching.
This spontaneous report was received from a 68-years-old consumer who refers on herself. There was no information about the patient's medical history provided. The patient did not have any known drug reactions or allergies. The patient's concurrent conditions included high blood pressure. The patient's concomitant therapies included CRESTOR and an "unspecified blood pressure medication". On an unspecified date in 2013, the patient was vaccinated with a dose of ZOSTAVAX subcutaneously (dose, frequency, lot# and expiration date were not reported) for prevention of herpes zoster. On 03-SEP-2017, the patient was diagnosed with shingles when she saw an "express urgent care" physician. The physician stated the patient "has shingles on her back". The patient was put on VALTREX to treat the shingles. There were no lab diagnostic studies performed. The patient was concerned that because she was "near her grandson if he will contract anything" and in addition wanted to know if she "need a revaccination for herself and her husband". The outcome of shingles was reported as not recovered. The relatedness between the event and ZOSTAVAX was not reported.
One day post vax mother noticed left arm swelling, red and warm to the touch. Pt was treated with Tylenol. Two days post onset the was seen in clinic and left arm remained red and swollen from the elbow to the shoulder moving arm without pain, walking, playing. Advise to apply warm compresses and baths. Return to clinic if worse to ER.
Had GARDASIL vaccine 8/6/14 - On 8/7/14 woke up with small dots on face and hive on elbow. Hives progressed on lt arm to wrist. Mom gave BENADRYL and hives went away but returned later. This time hives covered both arms and face. Mom advised to continue BENADRYL until hives do not return.
Fever, redness, swelling, warmth right arm (upper arm circ 21.75 cm vs 17cm left)
About 2 minutes after vaccines given, Tdap first, then shingles vaccine, client c/o itching at shingles site. Within about 5 minutes client c/o "tightness in chest like big dog sitting on chest: "Got client some water and she sat in waiting area. Talked with client about total of seven minutes since vaccine. Client flushed stated chest tightness worse. Got another PHN and took client to room. About 10 minutes after vaccines, client stated "Tongue feeling funny and a little swollen." Employee gave 0.5 mg IM Epi, at 5 minutes after vaccines, HR 68 SBP 148/70, before Epi 150/70, after Epi 158/80. Client stated "Feeling better," after Epi, about 5 minutes after Epi, client c/o chest tightness. Call 911 and client went to ER in ambulance to further assess client.
Mother phoned office to state pt. vomiting today, and feels it is an adverse reaction, declined appointment.
Priorix in the freezer and it was exposed to -22.4 F and it was administered to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a female patient who received MMR (Priorix) (batch number 2AR75, expiry date 11-MAY-2024) for prophylaxis.   On 16-MAY-2023, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced incorrect storage of drug (Verbatim: Priorix in the freezer and it was exposed to -22.4 F and it was administered to a patient). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 22-MAY-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow up via postal. The reporter stated that they stored Priorix in the freezer and it was exposed to -22.4 degree F and it was administered to a patient, which led to incorrect storage of drug.
Pt recv vax on 4/9/98; within 24 hrs pt exp a large, red, hot local area.  On 7/22/98 pt had a large welt on arm that finally faded; pt recovered.
Mass on neck, headaches, joint pain, memory loss (short term), lack of concentration, loss of sleep, numbness R fore arm weakness.
This spontaneous report was received from a registered nurse refers to an 11 year old female patient. No medical history or drug reactions were reported. On 30-JUL-2013, the patient was vaccinated with dose 1 of GARDASIL (lot # H021346). Concomitant therapies included MENACTRA, VAQTA and BOOSTRIX. On 30-JUL-2013, the patient developed a fever, felt dizzy and tired with leg and knee pain, loss of appetite and felt weak with body aches following vaccination with the first dose of GARDASIL. The nurse reported that the patient's mom also called the office today on 08-Aug-2013 and reported that immediately following the GARDASIL vaccination the patient had a fever, felt dizzy and tired and had leg and knee pain. The patient's mom also reported that today on 08-AUG-2013, the patient had no appetite, felt weak and had body aches. Patient sought medical attention-contacted office. No treatment was given to patient. No laboratory tests were performed. The outcomes of the events were reported as not recovered. Additional information is not expected.
no adverse effects; Improperly stored administered doses; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided.  On 14-MAY-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # R034394, expiration date 27-NOV-2020; dose and route unknown) for prophylaxis. The vaccine was exposed to temperature excursion from -14 to 10 degrees Celsius (C) for 15 hours. Data logger involved. There was no previous temperature excursion. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA000180:
I received what I thought was a Covid vaccination but upon looking back at the documentation my vaccination is listed as other and has the identifier of 043A21A. I received this at Clinic Pharmacy. Maybe it is coincidental but the identifier happens to match an unsecure public wireless network on my computer and cellular phone that I am unable to get rid of.
Initially after the injection I had side effects like sore arm, pounding headache, and didn't feel great. One month later I had some COVID-19 like symptoms like chills, fatigue, body aches, low grade fever, and they tested me and it was negative. It did push my 2nd dose out about 10 days. I had very bad fatigue and I already have chronic fatigue and I've been on disability since June. I was out of work for a while and tried going back in September but I still didn't feel great.
Caller experiencing Pain in right breast and under arm after receiving vaccine; Caller experiencing Pain in right breast and under arm after receiving vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BREAST PAIN (non-serious), AXILLARY PAIN (non-serious), outcome "unknown" and all described as "Caller experiencing Pain in right breast and under arm after receiving vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4 hours after immunization, mom describes high tactile temperature, constant crying, shaking, increased salivation.  Symptoms lasted approximately 12 hours.  Did not seek medical care.
Headache, Myalgia, Fever, Swelling Narrative:  Patient had body aches, fever, swelling at injection site on 12/3/20 and headache on 01/03/21. Used OTC benadryl.
Received vaccine 10/1/15 - 10/2/15 developed itching and redness at site. 10/4 developed stiff neck. 10/6 developed fever.
This spontaneous report was received from a licensed practical nurse refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ROTATEQ (lot# M019707 and expiry date 25-OCT-2017) orally. No adverse effects were reported. The administered vaccine was exposed to temperature excursion of 32.7 Fahrenheit for 2 hours and 15 minutes and 33.1 Fahrenheit for 4 hours. The vaccine was exposed to previous temperature excursion of 60.1 Fahrenheit for 14 hours and 15 minutes. Data digital logger was involved. No product quality complaint (PQC) was filed. This case is one of several reports received from the same reporter. Additional information has been requested.
This is a spontaneous report from a contactable consumer reporting for herself. A 75-year-old female patient received PREVNAR 13, via an unspecified route of administration in right shoulder up high, on 01Nov2016, at single dose, for immunisation. Medical history included ongoing dyspepsia, ongoing anxiety, ongoing blood pressure and neck injury. Concomitant medication included PROTONIX tablet, from a few years and ongoing, at 40 mg 2x/day (one in morning before she eats and one at night before she eats), for indigestion; atenolol tablet, from quite a long time and ongoing, at 25 mg 1x/day (1/2 tablet now, before a tablet), for blood pressure; XANAX 0.25 mg tablet, 1 DF (dosage form) 2x/day, as needed and vitamins (unspecified trade name), from an unspecified date and ongoing, daily. Patient's height was about 5-2 (unit not provided) and weight about 138 (unit not provided). The patient experienced arm hurt for couple of days on an unspecified date with outcome of unknown, headache in Nov2016 with outcome of recovering and red spot on arm on 06Nov2016 with outcome of recovering. Therapeutic measures were taken as a result of arm hurt for couple of days and red spot on arm and included treatment with BENADRYL and hot and cold compresses.
feeling unwell; cough; This is a spontaneous report from a contactable consumer (herself). A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1 via an unspecified route of administration as a single dose on 03Apr2021 for COVID-19 immunization. Medical history and concomitant medications were not reported. On 21Apr2021 (3 days prior to her second dose appointment), the patient experienced feeling unwell and cough. The patient was scheduled for second dose for 24Apr2021 at 14:00, but she called to cancel and make another appointment because of her symptoms. The outcome of the events of feeling unwell and cough was unknown.   No follow up attempts are needed. No further information is expected.
Upper left arm developed a large area (about 6 inches long and 3 inches wide) that was red, swollen and slightly itchy for about 5 days.  These symptoms began 8 days after the vaccine was given.  The affected area  was located about 2 inches below injection site.
Fever, aches and pain all over body, heart beating irregularly and beating hard with pain.
Extremely tired back muscles; body heat; felt unstable; lost a lot of sleep; could not lay prone; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration on 01Feb2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced Extremely tired back muscles, body heat, felt unstable, lost a lot of sleep, and could not lay prone. Caller declined to complete a report and requested to be transferred to USMI to have her questions addressed. The outcome for all the events was unknown.  Information on the lot/batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Dose administered at 1346 on July 7, 2021  into left arm. At 1401 patient complained of chest heaviness and some scratchiness. Gave patient water. At 1405 patient was encouraged to take 2 puffs of her Albuterol Inhaler. Complaints of chest tightness did not subside and patient continued to be undecided if it was related to her asthma or not. Blood pressures taken over the course of the next hour were 176/96, 188/98, and 184/98. Pulse oximetries were 97%-98%. Heart rate dropped from 80s to 70s to 60s. At 1515 a medical first response was called for the patient who was transferred to the Emergency Department for ongoing observation.
This spontaneous report as received from a pharmacy technician refers to a 4-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On 13-MAR-2018, the patient was vaccinated with improperly stored dose of Oka/Merck VARIVAX (lot # N022979, expiry date: 23-AUG-2019) (dose, frequency and route were not reported) for prophylaxis. No adverse effect was reported. The Oka/Merck VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1802USA001558.